EDAP to Participate in the UBS Global Healthcare Conference
EDAP (Nasdaq: EDAP) will participate in the UBS Global Healthcare Conference held November 10-13, 2025 in Palm Beach Gardens, Florida. CEO Ryan Rhodes and CFO Ken Mobeck are scheduled to host one-on-one investor meetings on Monday, November 10, 2025 at PGA National Resort Hotel.
Meetings are 1x1 investor sessions; registration is via UBS for clients or through a UBS sales representative.
EDAP (Nasdaq: EDAP) parteciperà alla UBS Global Healthcare Conference che si terrà dal 10 al 13 novembre 2025 a Palm Beach Gardens, Florida. CEO Ryan Rhodes e CFO Ken Mobeck sono previsti per incontri one-on-one con gli investitori lunedì 10 novembre 2025 presso l'hotel PGA National Resort.
Gli incontri sono sessioni investitore 1x1; la registrazione è tramite UBS per i clienti o tramite un rappresentante di vendita UBS.
EDAP (Nasdaq: EDAP) participará en la UBS Global Healthcare Conference que se celebrará del 10 al 13 de noviembre de 2025 en Palm Beach Gardens, Florida. CEO Ryan Rhodes y CFO Ken Mobeck están programados para realizar reuniones cara a cara con inversores el lunes 10 de noviembre de 2025 en el PGA National Resort Hotel.
Las reuniones son sesiones 1x1; la inscripción es a través de UBS para clientes o mediante un representante de ventas de UBS.
EDAP (나스닥: EDAP)은 2025년 11월 10-13일 플로리다주 팜 비치 가든스에서 열리는 UBS Global Healthcare Conference에 참여합니다. CEO Ryan Rhodes와 CFO Ken Mobeck은 2025년 11월 10일 월요일 PGA National Resort Hotel에서 1:1 투자자 미팅을 주재할 예정입니다.
미팅은 1대1 투자자 세션이며, 등록은 UBS 고객 또는 UBS 영업 담당자를 통해 진행됩니다.
EDAP ( Nasdaq : EDAP ) participera à la UBS Global Healthcare Conference qui se tiendra du 10 au 13 novembre 2025 à Palm Beach Gardens, en Floride. CEO Ryan Rhodes et CFO Ken Mobeck sont prévus pour des entretiens investisseurs en tête-à-tête le lundi 10 novembre 2025 à l'hôtel PGA National Resort.
Les réunions sont des sessions investisseurs en tête-à-tête; l'inscription se fait via UBS pour les clients ou par l'intermédiaire d'un représentant commercial UBS.
EDAP (Nasdaq: EDAP) wird an der UBS Global Healthcare Conference teilnehmen, die vom 10. bis 13. November 2025 in Palm Beach Gardens, Florida, stattfindet. CEO Ryan Rhodes und CFO Ken Mobeck sind vorgesehen, am Montag, dem 10. November 2025 im PGA National Resort Hotel einzelne Investorengespräche zu führen.
Die Meetings sind 1x1-Investorensitzungen; die Registrierung erfolgt über UBS für Kunden oder durch einen UBS-Vertriebsmitarbeiter.
EDAP (ناسداك: EDAP) ستشارك في مؤتمر UBS Global Healthcare الذي سيعقد في 10-13 نوفمبر 2025 في بالم بيتش جاردنز، فلوريدا. الرئيس التنفيذي رايان رودس و المدير المالي كين موبيك من المقرر أن يستضيفا اجتماعات مستثمرين وجهاً لوجه في الإثنين 10 نوفمبر 2025 في فندق PGA National Resort.
الاجتماعات هي جلسات مستثمرين فردية 1x1؛ التسجيل هو عبر UBS للعملاء أو من خلال ممثل مبيعات UBS.
EDAP (纳斯达克：EDAP) 将参加 UBS Global Healthcare Conference，时间为 2025 年 11 月 10-13 日，地点在佛罗里达州帕姆比治花园。CEO Ryan Rhodes 和 CFO Ken Mobeck 计划在 2025 年 11 月 10 日，星期一 于 PGA National Resort Hotel 主持一对一的投资者会面。
会谈为 1x1 投资者会话；注册通过 UBS 面向客户或通过 UBS 销售代表进行。
- None.
- None.
EDAP to Participate in the UBS Global Healthcare Conference
Company to Host 1x1 Investor Meetings on Monday, November 10th, 2025
AUSTIN, Texas, October 27, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, and Ken Mobeck, Chief Financial Officer, are scheduled to host 1x1 investor meetings at the upcoming UBS Global Healthcare Conference, which is being held November 10-13, 2025, in Palm Beach Gardens, Florida.
Date: Monday, November 10th
Format: 1x1 investor meetings
Location: PGA National Resort Hotel, Palm Beach Gardens, Florida
Registration: Click here to register for the conference (for UBS clients only), or please contact your UBS sales representative.
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/.
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
FAQ
When will EDAP (Nasdaq: EDAP) hold investor meetings at the UBS Global Healthcare Conference in 2025?
Who from EDAP will attend the UBS Global Healthcare Conference on November 10, 2025?
Where are EDAP's investor meetings at the UBS Global Healthcare Conference taking place?
How can investors register for EDAP meetings at the UBS Global Healthcare Conference November 2025?
What format will EDAP use for investor interactions at the UBS Global Healthcare Conference?
What are the dates of the UBS Global Healthcare Conference where EDAP is participating?
